GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Ascelia Pharma ACE.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.53

-5.73%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2025

Net income

−SEK 76.3m

FY2017FY2025

Free cash flow

−SEK 72.3m

FY2017FY2025

Shareholders' equity

SEK 99.5m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross profit−SEK 888,000−SEK 938,000−SEK 1.0m−SEK 3.9m−SEK 8.7m−SEK 825,000−SEK 62,000−SEK 2.5m—
Research and developmentSEK 56.8mSEK 50.8mSEK 81.3mSEK 118.1mSEK 107.6mSEK 64.8mSEK 26.9mSEK 15.6mSEK 9.4m
Operating income−SEK 74.1m−SEK 67.8m−SEK 110.9m−SEK 147.0m−SEK 137.9m−SEK 93.4m−SEK 36.7m−SEK 37.4m−SEK 24.7m
Net income−SEK 76.3m−SEK 80.0m−SEK 109.3m−SEK 131.2m−SEK 125.9m−SEK 98.7m−SEK 39.9m−SEK 37.1m−SEK 24.4m
Diluted earnings per share-0.60-0.83-3.24-3.90-3.10-3.45-1.70-1.14-0.75

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsSEK 111.9mSEK 140.9mSEK 87.1mSEK 218.6mSEK 333.5mSEK 255.4mSEK 250.2mSEK 287.4mSEK 116.1m
Cash and short-term investmentsSEK 49.9mSEK 75.3mSEK 21.9mSEK 149.6mSEK 261.6mSEK 184.7mSEK 184.2mSEK 225.0mSEK 55.1m
Total liabilitiesSEK 12.5mSEK 62.0mSEK 12.7mSEK 37.7mSEK 25.7mSEK 19.3mSEK 13.2mSEK 11.3mSEK 4.4m
DebtSEK 1.0mSEK 25.4mSEK 1.1mSEK 484,000SEK 1.7mSEK 1.8mSEK 215,000SEK 146,000—
Shareholders' equitySEK 99.5mSEK 78.9mSEK 74.3mSEK 180.9mSEK 307.8mSEK 236.1mSEK 237.1mSEK 276.1mSEK 111.7m
Shares outstanding127m96m34m34m41m29m23m33m33m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−SEK 72.3m−SEK 62.8m−SEK 126.8m−SEK 125.3m−SEK 116.6m−SEK 85.5m−SEK 36.9m−SEK 30.3m−SEK 21.0m
Capital spending−SEK 57,000—−SEK 126.8m−SEK 65,000−SEK 38,000−SEK 397,000−SEK 397,000−SEK 397,000−SEK 397,000
Free cash flow−SEK 72.3m−SEK 62.8m−SEK 253.6m−SEK 125.3m−SEK 116.6m−SEK 85.9m−SEK 37.3m−SEK 30.7m−SEK 21.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−SEK 12.2m−SEK 17.3m−SEK 15.5m−SEK 15.3m−SEK 23.0m−SEK 20.3m−SEK 21.9m−SEK 17.8m
Net income−SEK 12.2m−SEK 16.4m−SEK 15.9m−SEK 15.7m−SEK 23.0m−SEK 21.7m−SEK 28.3m−SEK 21.7m
Diluted earnings per share-0.09-0.12-0.13-0.12-0.18-0.17-0.29-0.23
Cash from operations−SEK 13.0m−SEK 15.0m−SEK 21.0m−SEK 15.0m−SEK 17.0m—−SEK 18.0m−SEK 17.0m
Total assetsSEK 100.2mSEK 96.9mSEK 111.9mSEK 136.4mSEK 125.3mSEK 123.0mSEK 140.9mSEK 161.4m
Cash and short-term investmentsSEK 38.0mSEK 33.9mSEK 49.9mSEK 72.3mSEK 60.4mSEK 57.3mSEK 75.3mSEK 95.7m
DebtSEK 521,000SEK 689,000SEK 970,000SEK 1.2mSEK 8.2mSEK 27.2mSEK 25.4mSEK 26.6m
Shareholders' equitySEK 89.8mSEK 82.9mSEK 99.5mSEK 114.4mSEK 93.7mSEK 57.8mSEK 78.9mSEK 107.6m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-20.4%-4.5%—
Net income-16.6%-5.0%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings-1.3-0.9-0.2-0.2-0.3-0.5-0.4

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.